Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

373 trials

NCT07061288
Recruiting
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Phase 1 · United States · 8 sites
Registry update: 2 Sept 2026
NCT07098169
Recruiting
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
Not applicable · United States · 3 sites
Registry update: 23 Jan 2026
NCT07121166
Recruiting
Tele-group Cognitive Behavioural Family Intervention for Individuals With Schizophrenia and Their Families (Definitive tgCBFI)
Not applicable · Hong Kong · 6 sites
Registry update: 24 Jul 2026
NCT07105111
Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Phase 4 · United States · 19 sites
Registry update: 18 Sept 2026
NCT07122531
Recruiting
Recovery With Exogenous Ketones and Antipsychotics
Not applicable · Canada · 1 site
Registry update: 22 May 2026
NCT07230652
Recruiting
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Phase 1 · China · 1 site
Registry update: 19 Nov 2025
NCT06911723
Recruiting
Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
Not applicable · United States · 1 site
Registry update: 31 Aug 2026
NCT07671261
Recruiting
SEEG-Guided DBS for Schizophrenia
Not applicable · China · 1 site
Registry update: 26 Jun 2026
NCT06887192
Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Phase 2 · Argentina, Bulgaria, Canada, Chile, Czechia, France, Hungary, Italy, South Korea, Poland, Portugal, Romania, Serbia, Slovakia, United States · 73 sites
Registry update: 30 Sept 2026
NCT07105098
Recruiting
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Phase 3 · Bulgaria, Hungary, Romania, Serbia, United States · 22 sites
Registry update: 25 Sept 2026
NCT06817980
Recruiting
Disorders of the Sense of Self and Physical Activity
Not applicable · France · 1 site
Registry update: 20 Aug 2026
NCT06687694
Recruiting
Immune Mechanisms of Antipsychotic Treatment Response
Not applicable · United Kingdom · 1 site
Registry update: 25 Mar 2026
NCT07145918
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Phase 2 · United States · 7 sites
Registry update: 15 Sept 2026
NCT07185815
Recruiting
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
Phase 1/2 · Israel, India · 6 sites
Registry update: 1 May 2026
NCT07093671
Recruiting
Mentalization Based Treatment (MBT) in Help Seeking Youths With a Clinical High-Risk Condition for Psychosis (CHR-P)
Not applicable · Switzerland · 1 site
Registry update: 8 Jul 2026
NCT07114874
Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Phase 3 · Bulgaria, Hungary, Puerto Rico, Romania, Serbia, United States · 62 sites
Registry update: 25 Sept 2026
NCT07045142
Recruiting
Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
Phase 3 · China · 8 sites
Registry update: 3 Aug 2026
NCT06929533
Recruiting
Pharmacogenomics-Supported Psychotropic Prescribing Trial
Not applicable · Canada · 2 sites
Registry update: 8 Sept 2025
NCT07234708
Recruiting
Feeling Safe Study
Not applicable · Spain · 1 site
Registry update: 21 Nov 2025
NCT06865937
Recruiting
Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
Not applicable · United States · 1 site
Registry update: 23 Feb 2026

Ordered by registry start date. Freshness and sponsorship never change the order.